nach oben

Journal of Cardiovascular Translational Research

Erschienen in:

01.10.2011

Biomaterials Advances in Patches for Congenital Heart Defect Repair

verfasst von: Seokwon Pok, Jeffrey G. Jacot

Erschienen in: Journal of Cardiovascular Translational Research | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

This article reviews current applications and novel candidate biomaterials for use as tissue-engineered scaffolds in pediatric cardiac tissue engineering. This overview of different types of biomaterials includes naturally derived and synthetic polymers and their biological, physical, and biomechanical properties for the use as a patch or baffle for surgical reconstruction of congenital heart defects. Applications and characteristics of composite biomaterials are highlighted with their respective feasibilities in use as cardiac scaffolds. Currently, a wide range of biomaterials has been introduced for cardiovascular reconstruction for complex congenital cardiac defects. However, there are still many remaining challenges for engineered tissue implantations.

Martin, J. A., Kung, H. C., Mathews, T. J., Hoyert, D. L., Strobino, D. M., Guyer, B., et al. (2008). Annual summary of vital statistics: 2006. Pediatrics, 121(4), 788–801.PubMedCrossRef

Kung HC, H. D., Xu, J., & Murphy, S. L. (2008). Deaths: Final data for 2005. National Vital Statistics Reports, 56(10), 1–124.PubMed

Silka, M. J., Hardy, B. G., Menashe, V. D., & Morris, C. D. (1998). A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. Journal of the American College of Cardiology, 32(1), 245–251.PubMedCrossRef

Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De Simone, G., et al. (2010). Executive summary: Heart disease and stroke statistics–2010 update: A report from the American Heart Association. Circulation, 121(7), 948–954.PubMedCrossRef

Reller, M. D., Strickland, M. J., Riehle-Colarusso, T., Mahle, W. T., & Correa, A. (2008). Prevalence of congenital heart defects in metropolitan Atlanta, 1998–2005. Journal of Pediatrics, 153(6), 807–813.PubMedCrossRef

Mirensky, T., & Breuer, C. K. (2008). The development of tissue engineered grafts for reconstructive cardiothoracic surgical applications. Pediatric Research, 63, 559–568.PubMedCrossRef

Mayer, J. E., Jr. (1995). Uses of homograft conduits for right ventricle to pulmonary artery connections in the neonatal period. Seminars in Thoracic and Cardiovascular Surgery, 7(3), 130–132.PubMed

Kim, B. S., Baez, C. E., & Atala, A. (2000). Biomaterials for tissue engineering. World Journal of Urology, 18(1), 2–9.PubMedCrossRef

Mooney, D. J., Baldwin, D. F., Suh, N. P., Vacanti, J. P., & Langer, R. (1996). Novel approach to fabricate porous sponges of poly(D, L-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials, 17(14), 1417–1422.PubMedCrossRef

10.

Dhandayuthapani, B., Krishnan, U. M., & Sethuraman, S. (2010). Fabrication and characterization of chitosan–gelatin blend nanofibers for skin tissue engineering. Journal of Biomedical Materials Research. Part B, Applied Biomaterials, 94(1), 264–272 [Research Support, Non-U.S. Gov't].PubMed

11.

Sherwood, J. K., Riley, S. L., Palazzolo, R., Brown, S. C., Monkhouse, D. C., Coates, M., et al. (2002). A three-dimensional osteochondral composite scaffold for articular cartilage repair. Biomaterials, 23(24), 4739–4751.PubMedCrossRef

12.

Madihally, S. V., & Matthew, H. W. (1999). Porous chitosan scaffolds for tissue engineering. Biomaterials, 20(12), 1133–1142.PubMedCrossRef

13.

Moshfeghian, A., Tillman, J., & Madihally, S. V. (2006). Characterization of emulsified chitosan–PLGA matrices formed using controlled-rate freezing and lyophilization technique. Journal of Biomedical Materials Research. Part A, 79(2), 418–430.PubMedCrossRef

14.

Joesten, M. D., & Wood, J. L. (1993). The world of chemistry (2nd ed.). Fort Worth: Saunders College.

15.

Eschenhagen, T., & Zimmermann, W. H. (2005). Engineering myocardial tissue. Circulation Research, 97(12), 1220–1231.PubMedCrossRef

16.

Seliktar, D., Black, R. A., Vito, R. P., & Nerem, R. M. (2000). Dynamic mechanical conditioning of collagen-gel blood vessel constructs induces remodeling in vitro. Annals of Biomedical Engineering, 28(4), 351–362.PubMedCrossRef

17.

Radisic, M., Park, H., Shing, H., Consi, T., Schoen, F. J., Langer, R., et al. (2004). Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proceedings of the National Academy of Sciences of the United States of America, 101(52), 18129–18134.PubMedCrossRef

18.

Shin, M., Ishii, O., Sueda, T., & Vacanti, J. P. (2004). Contractile cardiac grafts using a novel nanofibrous mesh. Biomaterials, 25(17), 3717–3723.PubMedCrossRef

19.

Stankus, J. J., Guan, J., & Wagner, W. R. (2004). Fabrication of biodegradable elastomeric scaffolds with sub-micron morphologies. Journal of Biomedical Materials Research. Part A, 70(4), 603–614.PubMed

20.

Hu, M., Kurisawa, M., Deng, R., Teo, C.-M., Schumacher, A., Thong, Y.-X., et al. (2009). Cell immobilization in gelatin-hydroxyphenylpropionic acid hydrogel fibers. Biomaterials, 30(21), 3523–3531.PubMedCrossRef

21.

Mao, J., Zhao, L., De Yao, K., Shang, Q., Yang, G., & Cao, Y. (2003). Study of novel chitosan–gelatin artificial skin in vitro. Journal of Biomedical Materials Research, 64A(2), 301–308.CrossRef

22.

Pangburn, S. H., Trescony, P. V., & Heller, J. (1982). Lysozyme degradation of partially deacetylated chitin, its films and hydrogels. Biomaterials, 3(2), 105–108.PubMedCrossRef

23.

DeLeon, S. Y., LoCicero, J., 3rd, Ilbawi, M. N., & Idriss, F. S. (1986). Repeat median sternotomy in pediatrics: experience in 164 consecutive cases. The Annals of Thoracic Surgery, 41(2), 184–188.PubMedCrossRef

24.

Sakai, T., Li, R. K., Weisel, R. D., Mickle, D. A., Kim, E. T., Jia, Z. Q., et al. (2001). The fate of a tissue-engineered cardiac graft in the right ventricular outflow tract of the rat. The Journal of Thoracic and Cardiovascular Surgery, 121(5), 932–942.PubMedCrossRef

25.

Ozawa, T., Mickle, D. A., Weisel, R. D., Koyama, N., Wong, H., Ozawa, S., et al. (2002). Histologic changes of nonbiodegradable and biodegradable biomaterials used to repair right ventricular heart defects in rats. The Journal of Thoracic and Cardiovascular Surgery, 124(6), 1157–1164.PubMedCrossRef

26.

Matsumura, G., Shin’oka, T., Ikada, Y., Sakamoto, T., & Kurosawa, H. (2008). Novel anti-adhesive pericardial substitute for multistage cardiac surgery. Asian Cardiovascular & Thoracic Annals, 16(4), 309–312.

27.

VandeVord, P. J., Matthew, H. W., DeSilva, S. P., Mayton, L., Wu, B., & Wooley, P. H. (2002). Evaluation of the biocompatibility of a chitosan scaffold in mice. Journal of Biomedical Materials Research, 59(3), 585–590.PubMedCrossRef

28.

Choi, B. K., Kim, K. Y., Yoo, Y. J., Oh, S. J., Choi, J. H., & Kim, C. Y. (2001). In vitro antimicrobial activity of a chitooligosaccharide mixture against Actinobacillus actinomycetemcomitans and Streptococcus mutans. International Journal of Antimicrobial Agents, 18(6), 553–557.PubMedCrossRef

29.

Risbud, M. V., Hardikar, A. A., Bhat, S. V., & Bhonde, R. R. (2000). pH-sensitive freeze-dried chitosan-polyvinyl pyrrolidone hydrogels as controlled release system for antibiotic delivery. Journal of Controlled Release, 68(1), 23–30.PubMedCrossRef

30.

Ishihara, M., Obara, K., Nakamura, S., Fujita, M., Masuoka, K., Kanatani, Y., et al. (2006). Chitosan hydrogel as a drug delivery carrier to control angiogenesis. Journal of Artificial Organs, 9(1), 8–16.PubMedCrossRef

31.

Kurdi, M., Chidiac, R., Hoemann, C., Zouein, F., Zgheib, C., & Booz, G. W. (2010). Hydrogels as a platform for stem cell delivery to the heart. Congestive Heart Failure, 16(3), 132–135.PubMedCrossRef

32.

Ren, D., Yi, H., Wang, W., & Ma, X. (2005). The enzymatic degradation and swelling properties of chitosan matrices with different degrees of N-acetylation. Carbohydrate Research, 340(15), 2403–2410 [Research Support, Non-U.S. Gov’t].PubMedCrossRef

33.

Sun, W., Darling, A., Starly, B., & Nam, J. (2004). Computer-aided tissue engineering: Overview, scope and challenges. Biotechnology and Applied Biochemistry, 39(Pt 1), 29–47.PubMedCrossRef

34.

Blan, N. R., & Birla, R. K. (2008). Design and fabrication of heart muscle using scaffold-based tissue engineering. Journal of Biomedical Materials Research. Part A, 86(1), 195–208.PubMedCrossRef

35.

Mei, N., Chen, G., Zhou, P., Chen, X., Shao, Z. Z., Pan, L. F., et al. (2005). Biocompatibility of poly(epsilon-caprolactone) scaffold modified by chitosan—the fibroblasts proliferation in vitro. Journal of Biomaterials Applications, 19(4), 323–339.PubMedCrossRef

36.

Wei, X., Gong, C., Gou, M., Fu, S., Guo, Q., Shi, S., et al. (2009). Biodegradable poly([var epsilon]-caprolactone)–poly(ethylene glycol) copolymers as drug delivery system. International Journal of Pharmaceutics, 381(1), 1–18. doi:10.1016/j.ijpharm.2009.07.033.PubMedCrossRef

37.

Birla, R. K., Borschel, G. H., Dennis, R. G., & Brown, D. L. (2005). Myocardial engineering in vivo: Formation and characterization of contractile, vascularized three-dimensional cardiac tissue. Tissue Engineering, 11(5–6), 803–813. Article.PubMedCrossRef

38.

Mol, A., van Lieshout, M. I., Dam-de Veen, C. G., Neuenschwander, S., Hoerstrup, S. P., Baaijens, F. P., et al. (2005). Fibrin as a cell carrier in cardiovascular tissue engineering applications. Biomaterials, 26(16), 3113–3121.PubMedCrossRef

39.

Park, J. B., Lee, J. Y., Park, Y. J., Rhee, S. H., Lee, S. C., Kim, T. I., et al. (2007). Enhanced bone regeneration in beagle dogs with bovine bone mineral coated with a synthetic oligopeptide. Journal of Periodontology, 78(11), 2150–2155.PubMedCrossRef

40.

Huang, Y. C., Dennis, R. G., Larkin, L., & Baar, K. (2005). Rapid formation of functional muscle in vitro using fibrin gels. Journal of Applied Physiology, 98(2), 706–713.PubMedCrossRef

41.

Jockenhoevel, S., Zund, G., Hoerstrup, S. P., Chalabi, K., Sachweh, J. S., Demircan, L., et al. (2001). Fibrin gel—advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardio-Thorac Surg., 19(4), 424–430. Proceedings Paper.CrossRef

42.

Christman, K. L., Fok, H. H., Sievers, R. E., Fang, Q. H., & Lee, R. J. (2004). Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Engineering, 10(3–4), 403–409. Article.PubMedCrossRef

43.

Christman, K. L., Vardanian, A. J., Fang, Q. Z., Sievers, R. E., Fok, H. H., & Lee, R. J. (2004). Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. Journal of the American College of Cardiology, 44(3), 654–660. Article.PubMedCrossRef

44.

Black, L. D., Meyers, J. D., Weinbaum, J. S., Shvelidze, Y. A., & Tranquillo, R. T. (2009). Cell-induced alignment augments twitch force in fibrin gel-based engineered myocardium via gap junction modification. Tissue Engineering. Part A, 15(10), 3099–3108.PubMedCrossRef

45.

Zhang, G., Wang, X., Wang, Z., Zhang, J., & Suggs, L. (2006). A PEGylated fibrin patch for mesenchymal stem cell delivery. Tissue Engineering, 12(1), 9–19.PubMedCrossRef

46.

Pankajakshan, D., Philipose, L. P., Palakkal, M., Krishnan, K., & Krishnan, L. K. (2008). Development of a fibrin composite-coated poly(epsilon-caprolactone) scaffold for potential vascular tissue engineering applications. Journal of Biomedical Materials Research. Part B, Applied Biomaterials, 87(2), 570–579. Research Support, Non-U.S. Gov’t.PubMedCrossRef

47.

Petrenko, Y. A., Ivanov, R. V., Petrenko, A. Y., & Lozinsky, V. I. (2011) Coupling of gelatin to inner surfaces of pore walls in spongy alginate-based scaffolds facilitates the adhesion, growth and differentiation of human bone marrow mesenchymal stromal cells. The Journal of Materials Science: Materials in Medicine. doi:10.1007/s10856-011-4323-6.

48.

Tan, H., & Marra, K. G. (2010). Injectable, biodegradable hydrogels for tissue engineering applications. Materials., 3(3), 1746–1767.CrossRef

49.

Leor, J., Aboulafia-Etzion, S., Dar, A., Shapiro, L., Barbash, I. M., Battler, A., et al. (2000). Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium? Circulation, 102(19 Suppl 3), III56–III61.PubMed

50.

Tee, R., Lokmic, Z., Morrison, W. A., & Dilley, R. J. (2010). Strategies in cardiac tissue engineering. ANZ Journal of Surgery, 80(10), 683–693.PubMedCrossRef

51.

Ren, Y.-J., Zhou, Z.-Y., Liu, B.-F., Xu, Q.-Y., & Cui, F.-Z. (2009). Preparation and characterization of fibroin/hyaluronic acid composite scaffold. International Journal of Biological Macromolecules, 44(4), 372–378. doi:10.1016/j.ijbiomac.2009.02.004.PubMedCrossRef

52.

Tudorache, I., Kostin, S., Meyer, T., Teebken, O., Bara, C., Hilfiker, A., et al. (2009). Viable vascularized autologous patch for transmural myocardial reconstruction. Eur J Cardio-Thorac Surg., 36(2), 306–311.CrossRef

53.

Vesely, I., & Mako, W. J. (1998). Comparison of the compressive buckling of porcine aortic valve cusps and bovine pericardium. The Journal of Heart Valve Disease, 7(1), 34–39.PubMed

54.

Huanglee, L. L. H., Cheung, D. T., & Nimni, M. E. (1990). Biochemical-changes and cytotoxicity associated with the degradation of polymeric glutaraldehyde derived cross-links. Journal of Biomedical Materials Research, 24(9), 1185–1201. Article.CrossRef

55.

Maizato, M. J. S., Pires, M. D., Canzian, M., Higa, O. Z., Pitombo, R. N. M., & Leirner, A. A. (2008). Histological evaluation of biocompatibility of lyophilized bovine pericardium implanted subcutaneously in rats. Artificial Organs, 32(4), 268–271. Proceedings Paper.PubMedCrossRef

56.

Santibanez-Salgado, J. A., Olmos-Zuniga, J. R., Perez-Lopez, M., Aboitiz-Rivera, C., Gaxiola-Gaxiola, M., Jasso-Victoria, R., et al. (2010). Lyophilized glutaraldehyde-preserved bovine pericardium for experimental atrial septal defect closure. European Cells & Materials, 19, 158–165.

57.

Prevel, C. D., Eppley, B. L., Summerlin, D. J., Sidner, R., Jackson, J. R., McCarty, M., et al. (1995). Small intestinal submucosa: Utilization as a wound dressing in full-thickness rodent wounds. Annals of Plastic Surgery, 35(4), 381–388.PubMedCrossRef

58.

Badylak, S. F., Tullius, R., Kokini, K., Shelbourne, K. D., Klootwyk, T., Voytik, S. L., et al. (1995). The use of xenogeneic small intestinal submucosa as a biomaterial for Achilles tendon repair in a dog model. Journal of Biomedical Materials Research, 29(8), 977–985.PubMedCrossRef

59.

Kropp, B. P., Eppley, B. L., Prevel, C. D., Rippy, M. K., Harruff, R. C., Badylak, S. F., et al. (1995). Experimental assessment of small intestinal submucosa as a bladder wall substitute. Urology, 46(3), 396–400.PubMedCrossRef

60.

Badylak, S., Obermiller, J., Geddes, L., & Matheny, R. (2003). Extracellular matrix for myocardial repair. The Heart Surgery Forum, 6(2), E20–E26.PubMed

61.

Crapo, P. M., & Wang, Y. D. (2010). Small intestinal submucosa gel as a potential scaffolding material for cardiac tissue engineering. Acta Biomaterialia, 6(6), 2091–2096. Article.PubMedCrossRef

62.

Tottey, S., Johnson, S. A., Crapo, P. M., Reing, J. E., Zhang, L., Jiang, H., et al. (2011). The effect of source animal age upon extracellular matrix scaffold properties. Biomaterials, 32(1), 128–136.PubMedCrossRef

63.

Place, E. S., George, J. H., Williams, C. K., & Stevens, M. M. (2009). Synthetic polymer scaffolds for tissue engineering. Chemical Society Reviews, 38(4), 1139–1151.PubMedCrossRef

64.

Pok, S. W., Wallace, K. N., & Madihally, S. V. (2010). In vitro characterization of polycaprolactone matrices generated in aqueous media. Acta Biomaterialia, 6(3), 1061–1068.PubMedCrossRef

65.

Zein, I., Hutmacher, D. W., Tan, K. C., & Teoh, S. H. (2002). Fused deposition modeling of novel scaffold architectures for tissue engineering applications. Biomaterials, 23(4), 1169–1185.PubMedCrossRef

66.

Nguyen, T. H., & Lee, B. T. (2010). Electro-spinning of PLGA/PCL blends for tissue engineering and their biocompatibility. Journal of Materials Science. Materials in Medicine, 21(6), 1969–1978.CrossRef

67.

van der Giessen, W. J., Lincoff, A. M., Schwartz, R. S., van Beusekom, H. M., Serruys, P. W., Holmes, D. R., Jr., et al. (1996). Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation, 94(7), 1690–1697.PubMed

68.

Li, W. J., Cooper, J. A., Jr., Mauck, R. L., & Tuan, R. S. (2006). Fabrication and characterization of six electrospun poly(alpha-hydroxy ester)-based fibrous scaffolds for tissue engineering applications. Acta Biomaterialia, 2(4), 377–385.PubMedCrossRef

69.

Htay, A. S., Teoh, S. H., & Hutmacher, D. W. (2004). Development of perforated microthin poly(epsilon-caprolactone) films as matrices for membrane tissue engineering. Journal of Biomaterials Science, Polymer Edition, 15(5), 683–700.CrossRef

70.

Aliabadi, H. M., Mahmud, A., Sharifabadi, A. D., & Lavasanifar, A. (2005). Micelles of methoxy poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A. Journal of Controlled Release, 104(2), 301–311.PubMedCrossRef

71.

Pitt, C. G., Gratzl, M. M., Kimmel, G. L., Surles, J., & Schindler, A. (1981). Aliphatic polyesters II. The degradation of poly (DL-lactide), poly (epsilon-caprolactone), and their copolymers in vivo. Biomaterials, 2(4), 215–220. Research Support, U.S. Gov’t, P.H.S.PubMedCrossRef

72.

Shin’oka, T., Matsumura, G., Hibino, N., Naito, Y., Watanabe, M., Konuma, T., et al. (2005). Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. The Journal of Thoracic and Cardiovascular Surgery, 129(6), 1330–1338.PubMedCrossRef

73.

Hutmacher, D. W., Goh, J. C., & Teoh, S. H. (2001). An introduction to biodegradable materials for tissue engineering applications. Annals Of The Academy Of Medicine, Singapore., 30(2), 183–191.PubMed

74.

Gunatillake, P. A., & Adhikari, R. (2003). Biodegradable synthetic polymers for tissue engineering. European Cells & Materials, 5, 1–16. discussion.

75.

Ke, Q., Yang, Y., Rana, J. S., Chen, Y., Morgan, J. P., & Xiao, Y. F. (2005). Embryonic stem cells cultured in biodegradable scaffold repair infarcted myocardium in mice. Sheng Li Xue Bao, 57(6), 673–681.PubMed

76.

Falco, E. E., Patel, M., & Fisher, J. P. (2008). Recent developments in cyclic acetal biomaterials for tissue engineering applications. Pharmaceutical Research, 25(10), 2348–2356.PubMedCrossRef

77.

Xue, L., & Greisler, H. P. (2003). Biomaterials in the development and future of vascular grafts. Journal of Vascular Surgery, 37(2), 472–480.PubMedCrossRef

78.

Park, H., Radisic, M., Lim, J. O., Chang, B. H., & Vunjak-Novakovic, G. (2005). A novel composite scaffold for cardiac tissue engineering. In Vitro Cellular & Developmental Biology. Animal, 41(7), 188–196. Article.CrossRef

79.

Natarajan, A., Chun, C. J., Hickman, J. J., & Molnar, P. (2008). Growth and electrophysiological properties of rat embryonic cardiomyocytes on hydroxyl- and carboxyl-modified surfaces. Journal of Biomaterials Science, Polymer Edition, 19(10), 1319–1331. Article.CrossRef

80.

Baskett, R. J., Ross, D. B., Nanton, M. A., & Murphy, D. A. (1996). Factors in the early failure of cryopreserved homograft pulmonary valves in children: Preserved immunogenicity? The Journal of Thoracic and Cardiovascular Surgery, 112(5), 1170–1178. discussion 8–9.PubMedCrossRef

81.

Seo, N. M., Ko, J. H., Park, Y. H., & Chun, H. J. (2011). In vitro biocompatibility of PLGA-HA nano-hybrid scaffold. Tissue Eng Regen Med, 8(1), 16–22. Article.

82.

Amato, J. J., Cotroneo, J. V., Galdieri, R. J., Alboliras, E., Antillon, J., & Vogel, R. L. (1989). Experience with the polytetrafluoroethylene surgical membrane for pericardial closure in operations for congenital cardiac defects. The Journal of Thoracic and Cardiovascular Surgery, 97(6), 929–934. Article.PubMed

83.

Kay, P. H., & Ross, D. N. (1985). Fifteen years’ experience with the aortic homograft: the conduit of choice for right ventricular outflow tract reconstruction. The Annals of Thoracic Surgery, 40(4), 360–364.PubMedCrossRef

84.

Li, R. K., Jia, Z. Q., Weisel, R. D., Mickle, D. A., Choi, A., & Yau, T. M. (1999). Survival and function of bioengineered cardiac grafts. Circulation, 100(19 Suppl), II63–II69.PubMed

85.

Sarasam, A. R., Samli, A. I., Hess, L., Ihnat, M. A., & Madihally, S. V. (2007). Blending chitosan with polycaprolactone: Porous scaffolds and toxicity. Macromolecular Bioscience, 7(9–10), 1160–1167.PubMedCrossRef

86.

Francis, L., Meng, D., Knowles, J. C., Roy, I., & Boccaccini, A. R. (2010). Multi-functional P(3HB) microsphere/45S5 Bioglass-based composite scaffolds for bone tissue engineering. Acta Biomaterialia, 6(7), 2773–2786.PubMedCrossRef

Titel: Biomaterials Advances in Patches for Congenital Heart Defect Repair
verfasst von: Seokwon Pok
Jeffrey G. Jacot
Publikationsdatum: 01.10.2011
Verlag: Springer US
Erschienen in: Journal of Cardiovascular Translational Research / Ausgabe 5/2011
Print ISSN: 1937-5387
Elektronische ISSN: 1937-5395
DOI: https://doi.org/10.1007/s12265-011-9289-8

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Biomaterials Advances in Patches for Congenital Heart Defect Repair

Abstract

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

Update Kardiologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2011

Biomaterials to Prevascularize Engineered Tissues

A Clinical Commentary on the Article “Patient-to-Patient Variability in Autologous Pericardial Matrix Scaffolds for Cardiac Repair”

Sensing the Cardiac Environment: Exploiting Cues for Regeneration

A Clinical Commentary on the Article “Injectable Acellular Hydrogels for Cardiac Repair”

The Biocompatibility Manifesto: Biocompatibility for the Twenty-first Century

Stem Cell-Based Cardiac Tissue Engineering

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

Update Kardiologie